Allbirds Inc vs Canopy Growth Corp — how do they compare? Allbirds Inc trades at $2.95 (market cap $26.33M), while Canopy Growth Corp trades at $1 (market cap $407.38M). The key difference: Canopy Growth Corp is far larger — about 15.5× Allbirds Inc's market cap. Which is the better fit depends on your goals.
| BIRD | CGC | |
|---|---|---|
Market Cap | $26.33M | $407.38M |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $1.92 |
52-Week Low | $2.39 | $0.86 |
Enterprise Value | $45.20M | $346.82M |
Signals from Pluang's Aura AI — not financial advice
BIRD (Smartbird) trades at $3.00, down 4.15% today, amid a complete pivot from footwear to AI infrastructure. The stock shows a bearish technical signal with flat support/resistance at $3.00, while oscillators like RSI indicate oversold conditions. Financially, revenue has declined from $298M in 2022 to $152M in 2025, with persistent net losses and negative cash flow. Recent news highlights the rebrand to Smartbird and new CEO appointment, driving volatility.
The outlook is highly speculative; the AI pivot offers growth potential but execution risks are severe given the company's unprofitable history and cash burn. Analyst consensus is cautious with 79% hold ratings. Investors face significant uncertainty around the new business model's viability and funding needs.
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Trailing returns across standard periods
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →